AGENDA AT A GLANCE
Leadership Panel Discussion
Building Global Vaccine Partnerships
8:50
Chairman Opening Remarks
9:00
Leadership Panel Discussion: Forging Global Vaccine Partnerships
- Transitioning from emergency-driven collaborations to sustained vaccine partnerships for both pandemics and endemic diseases.
- Leveraging cross-sector partnerships to create a resilient vaccine ecosystem that addresses long-term global health challenges.
- Building trust and transparency between governments, international organizations, and the private sector for lasting collaboration.
- Capitalizing on mRNA breakthroughs to establish a global vaccine network capable of addressing future health threats.
- Innovating data-sharing, regulatory harmonization, and global governance for a unified global health response.
9:50
Reserved for Solution Provider
10:15
Keynote Address: The Importance of Vaccines in Developing Countries
- The role of vaccines in reducing infectious diseases and improving public health in developing countries.
- How vaccination programs support economic stability by lowering healthcare costs and boosting productivity.
- The importance of vaccines in strengthening global health security and preventing disease spread.
10:40
Morning Break – Exhibition Viewing & 1-1 Networking
Next-Gen Vaccines for Developing Nations
Tailoring Vaccine Development
11:15
Rapid Development of Next-Gen Vaccines for Tropical Diseases
- Innovations in mRNA and viral vector vaccines for diseases like malaria and dengue.
- Streamlining R&D and production timelines for quicker deployment.
- The role of local manufacturing in reducing vaccine costs.
12:05
Improving Vaccine Formulation and Delivery for Developing Nations
- Developing stable vaccines that can withstand high temperatures and harsh conditions.
- Formulation strategies to increase vaccine shelf-life and efficacy in low-resource environments.
- Optimizing vaccine delivery mechanisms, such as needle-free injectors or oral vaccines.
12:30
Lunch – Exhibition Viewing & 1-1 Networking
Development of Vaccines for Emerging Diseases
Accelerating Vaccine Research for New Threats
2:00
Accelerating Vaccine Development for Emerging Diseases in Low-Resource Settings
- Modular vaccine platforms for rapid adaptation to new pathogens.
- Integration of AI and data analytics in the vaccine development process.
- Expediting regulatory approvals and global collaboration.
2:25
Reserved for Solution Providers
2:50
Early-Stage Research and Vaccine Target Identification
- Cutting-edge techniques for identifying early-stage vaccine targets.
- Bioinformatics and genomics in predicting potential vaccine candidates.
- Pre-clinical research and animal models for developing vaccines for new diseases.
3:15
Afternoon Break – Exhibition Viewing & 1-1 Networking
Essential Vaccines for Future Resilience
Long-term Health Security & Supportive Policies
4:00
Integrated Polishing Strategies: Achieving Purity with Fewer Steps
- Minimising DSP complexity while ensuring impurity removal.
- Tackling charge variants and aggregates with orthogonal approaches.
- Combining polishing steps to reduce cost and processing time.
4:25
Reserved for Solution Providers
4:50
International Policy Coordination for Global Vaccine Access
- Streamlining global regulatory policies to facilitate faster approvals.
- The role of multilateral organizations in financing global vaccine access.
- Addressing the legal and economic barriers to vaccine equity.
5:15
Chairman Closing Remarks
5:20
End of Conference - Day 1
5:20
Cocktails & Networking
6:00
ABEA Awards 2026
Breakthroughs in Vaccine Technologies
The Role of mRNA Platforms
8:55
Chairman Opening Remarks
9:00
Enhancing mRNA Vaccine Stability and Cost-Efficiency
- Innovations in mRNA storage and transport.
- Reducing production costs to increase accessibility.
- Leveraging local production facilities for mRNA vaccine production.
9:25
Reserved for Solution Provider
9:50
Optimizing RNA-Based Vaccine Platforms for Non-Infectious Diseases
- Expanding the role of RNA vaccines beyond infectious diseases to areas like cancer and autoimmune diseases.
- Advances in RNA modification techniques to improve stability and immune response.
- Overcoming challenges in scalability and manufacturing for large-scale distribution.
10:15
Morning Break – Exhibition Viewing & 1-1 Networking
Scaling Up Vaccine Manufacturing
New-Age Automations & Advanced Technologies
11:00
Integrating Automation in Vaccine Production for Efficiency and Scale
- Role of AI and robotics in improving vaccine production lines.
- Cost-saving automation technologies for high-volume production.
- Real-time quality control and data integration in vaccine production.
11:25
Reserved for Solution Provider
11:50
Innovations in Biomanufacturing to Meet Global Vaccine Demand
- Continuous biomanufacturing systems for faster production cycles.
- Ensuring scalability while maintaining quality in vaccine production.
- Innovations in cell culture and fermentation technologies for large-scale vaccine production.
12:15
Lunch – Exhibition Viewing & 1-1 Networking
Vaccine Technology Transfer
Vaccine Production Technologies for Global Accessibility
2:00
Strengthening Local Manufacturing Through Vaccine Technology Transfer
- Challenges and solutions for transferring technology to developing nations.
- Training local workforce and establishing production facilities.
- Ensuring sustainable production models through knowledge transfer.
2:25
Reserved for Solution Provider
2:50
Managing Intellectual Property in Vaccine Technology Transfer
- Balancing intellectual property protection with global vaccine equity.
- Leveraging public-private partnerships for technology sharing.
- Facilitating technology transfer agreements for equitable distribution.
3:15
Afternoon Break – Exhibition Viewing & 1-1 Networking
Cold Chain & Last-Mile Delivery
Maintaining Vaccine Integrity and Global Distribution
4:00
Overcoming Last-Mile Delivery Challenges in Remote Areas
- Mobile vaccine clinics and drone deliveries in hard-to-reach areas.
- Partnerships with local organizations for effective last-mile distribution.
- Innovations in packaging and transportation to maintain vaccine stability.
4:25
Reserved for Solution Provider
4:50
Cost-Effective Innovations in Cold Chain for Vaccine Distribution
- Low-cost, energy-efficient refrigeration solutions for remote areas.
- Real-time temperature monitoring systems for vaccine integrity.
- Overcoming infrastructure challenges in cold chain logistics.
Closing Panel: Forging India's Vaccine & Biologics Future
5:15
Leadership Panel: Shaping the Future of Novel Vaccines & Biologics – Innovations, Strategies, and Global Collaboration
- Explore recent innovations and technologies transforming the vaccines and biologics industry
- Discuss strategies for advancing affordable biologics and vaccines, especially in the Global South
- Identify opportunities for international collaboration to enhance vaccine and biologics development
- Address clinical trial challenges in developing countries for novel vaccines and biologics
Moderator:
Panelists:
5:55
Chairman Closing Remarks
6:00
End of Conference - Day 2
For Speaking Opportunities, Kindly Contact:
